All-new research in dermatology is available now – take a look at this month’s new and exclusive content on JDDonline.com:
- In a multicenter clinical study, investigators conduct an analysis of data on the Effect of Calcipotriene/Betamethasone Dipropionate 0.005%/0.064% Foam on Target Lesions in Plaque Psoriasis: A Post-Hoc Analysis
-
Authors evaluate Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia in a retrospective chart review of TA patients treated with ILK at an academic dermatology clinic.
-
Real-World Clinical Experience With the IL-17 Receptor A Antagonist Brodalumab highlights the safety and efficacy and unique mechanisms of action of the IL-17 inhibitors.
-
Real-World Clinical Experience With the IL-17 Receptor A Antagonist Brodalumab highlights the safety and efficacy and unique mechanisms of action of the IL-17 inhibitors.
- The IL-17 pathway plays a crucial role in the immunopathogenesis and development of psoriasis in Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in Psoriasis.
-
A Survey of Dermatologists’ Preparedness for Natural and Manmade Disasters examines whether the dermatology field has advanced in its bioterrorism preparedness since a 2003 survey revealed 88% of dermatologists felt unprepared to respond to a biological attack.
View all February JDD content, including editor’s picks, supplements, CME activities, case reports, and more!
Read Now
You May Also Like
Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders
Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders
AI in Dermatology: Vision Language Models Show Limited Accuracy for Nail Disorders in JDD Study In case you missed it, check out this article from the JDD. A recent study…
Objective Measures Needed: Dermatology Program Directors’ Perspectives on the USMLE Step 1 Pass/Fail Transition
Objective Measures Needed: Dermatology Program Directors’ Perspectives on the USMLE Step 1 Pass/Fail Transition
JDD Survey: How Dermatology Program Directors Are Responding to Step 1 Pass/Fail Have you read this article from the JDD? A new survey of dermatology residency program directors examine how…
Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
Phase 3 data report rapid, clinically meaningful symptom reduction with a tolerable safety profile; early hidradenitis suppurativa signals broaden interest Hot off the pages of JDD, this timely review synthesizes…
